SNCA and Parkinson disease: It has been suggested that the pattern of ɑ-synuclein aggregate formation in Parkinson's disease closely mirrors the pattern of contrast agent distribution in the brain parenchyma following intrathecal injection.30 Consequently, we speculate that the degeneration of these regions is initiated by the effects of neurotoxic proteins resulting from impaired glymphatic activity.